Go Pro

Concentrix (CNXC) Competitors

Concentrix logo
$25.50 -0.22 (-0.86%)
As of 04:00 PM Eastern

CNXC vs. QBTS, LYFT, HNGE, AMTM, and FTDR

Should you buy Concentrix stock or one of its competitors? MarketBeat compares Concentrix with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Concentrix include D-Wave Quantum (QBTS), Lyft (LYFT), Hinge Health (HNGE), Amentum (AMTM), and Frontdoor (FTDR).

How does Concentrix compare to D-Wave Quantum?

D-Wave Quantum (NASDAQ:QBTS) and Concentrix (NASDAQ:CNXC) are related companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

D-Wave Quantum currently has a consensus target price of $36.36, suggesting a potential upside of 80.08%. Concentrix has a consensus target price of $32.75, suggesting a potential upside of 28.43%. Given D-Wave Quantum's stronger consensus rating and higher probable upside, analysts clearly believe D-Wave Quantum is more favorable than Concentrix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
D-Wave Quantum
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.87
Concentrix
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17

In the previous week, D-Wave Quantum had 43 more articles in the media than Concentrix. MarketBeat recorded 47 mentions for D-Wave Quantum and 4 mentions for Concentrix. Concentrix's average media sentiment score of 0.89 beat D-Wave Quantum's score of 0.36 indicating that Concentrix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
D-Wave Quantum
15 Very Positive mention(s)
8 Positive mention(s)
15 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Neutral
Concentrix
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Concentrix has a net margin of -13.16% compared to D-Wave Quantum's net margin of -2,001.59%. Concentrix's return on equity of 19.82% beat D-Wave Quantum's return on equity.

Company Net Margins Return on Equity Return on Assets
D-Wave Quantum-2,001.59% -28.19% -25.02%
Concentrix -13.16%19.82%5.62%

42.5% of D-Wave Quantum shares are owned by institutional investors. Comparatively, 90.3% of Concentrix shares are owned by institutional investors. 1.3% of D-Wave Quantum shares are owned by company insiders. Comparatively, 0.9% of Concentrix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

D-Wave Quantum has higher earnings, but lower revenue than Concentrix. D-Wave Quantum is trading at a lower price-to-earnings ratio than Concentrix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
D-Wave Quantum$24.59M303.72-$355.06M-$0.71N/A
Concentrix$9.83B0.16-$1.28B-$21.32N/A

D-Wave Quantum has a beta of 2.15, suggesting that its stock price is 115% more volatile than the broader market. Comparatively, Concentrix has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

Summary

D-Wave Quantum beats Concentrix on 10 of the 17 factors compared between the two stocks.

How does Concentrix compare to Lyft?

Concentrix (NASDAQ:CNXC) and Lyft (NASDAQ:LYFT) are both industrials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Lyft has a net margin of 42.32% compared to Concentrix's net margin of -13.16%. Concentrix's return on equity of 19.82% beat Lyft's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentrix-13.16% 19.82% 5.62%
Lyft 42.32%-1.20%-0.36%

Concentrix currently has a consensus price target of $32.75, suggesting a potential upside of 28.43%. Lyft has a consensus price target of $19.80, suggesting a potential upside of 14.72%. Given Concentrix's higher possible upside, equities analysts clearly believe Concentrix is more favorable than Lyft.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentrix
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Lyft
2 Sell rating(s)
22 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.30

Concentrix has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Lyft has a beta of 1.8, indicating that its share price is 80% more volatile than the broader market.

In the previous week, Lyft had 42 more articles in the media than Concentrix. MarketBeat recorded 46 mentions for Lyft and 4 mentions for Concentrix. Concentrix's average media sentiment score of 0.89 beat Lyft's score of 0.51 indicating that Concentrix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concentrix
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Lyft
16 Very Positive mention(s)
8 Positive mention(s)
9 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Positive

Lyft has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Lyft, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentrix$9.83B0.16-$1.28B-$21.32N/A
Lyft$6.32B1.04$2.84B$6.882.51

90.3% of Concentrix shares are owned by institutional investors. Comparatively, 83.1% of Lyft shares are owned by institutional investors. 0.9% of Concentrix shares are owned by insiders. Comparatively, 0.9% of Lyft shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Lyft beats Concentrix on 10 of the 16 factors compared between the two stocks.

How does Concentrix compare to Hinge Health?

Concentrix (NASDAQ:CNXC) and Hinge Health (NYSE:HNGE) are related companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, Hinge Health had 22 more articles in the media than Concentrix. MarketBeat recorded 26 mentions for Hinge Health and 4 mentions for Concentrix. Concentrix's average media sentiment score of 0.89 beat Hinge Health's score of 0.61 indicating that Concentrix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concentrix
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
5 Very Positive mention(s)
4 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Concentrix presently has a consensus target price of $32.75, suggesting a potential upside of 28.43%. Hinge Health has a consensus target price of $100.57, suggesting a potential upside of 10.12%. Given Concentrix's higher possible upside, equities research analysts plainly believe Concentrix is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentrix
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Hinge Health
1 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
2 Strong Buy rating(s)
2.94

Hinge Health has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentrix$9.83B0.16-$1.28B-$21.32N/A
Hinge Health$587.86M12.02-$528.26M$1.2871.35

90.3% of Concentrix shares are owned by institutional investors. 0.9% of Concentrix shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hinge Health has a net margin of 15.15% compared to Concentrix's net margin of -13.16%. Hinge Health's return on equity of 65.44% beat Concentrix's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentrix-13.16% 19.82% 5.62%
Hinge Health 15.15%65.44%14.54%

Concentrix has a beta of 0.45, indicating that its stock price is 55% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

Summary

Hinge Health beats Concentrix on 13 of the 17 factors compared between the two stocks.

How does Concentrix compare to Amentum?

Amentum (NYSE:AMTM) and Concentrix (NASDAQ:CNXC) are both industrials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Amentum currently has a consensus target price of $32.00, suggesting a potential upside of 31.04%. Concentrix has a consensus target price of $32.75, suggesting a potential upside of 28.43%. Given Amentum's stronger consensus rating and higher probable upside, equities research analysts plainly believe Amentum is more favorable than Concentrix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amentum
1 Sell rating(s)
7 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47
Concentrix
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17

39.9% of Amentum shares are held by institutional investors. Comparatively, 90.3% of Concentrix shares are held by institutional investors. 19.4% of Amentum shares are held by company insiders. Comparatively, 0.9% of Concentrix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Amentum has a net margin of 1.04% compared to Concentrix's net margin of -13.16%. Concentrix's return on equity of 19.82% beat Amentum's return on equity.

Company Net Margins Return on Equity Return on Assets
Amentum1.04% 11.74% 4.78%
Concentrix -13.16%19.82%5.62%

Amentum has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market. Comparatively, Concentrix has a beta of 0.45, meaning that its stock price is 55% less volatile than the broader market.

Amentum has higher revenue and earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Amentum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amentum$14.20B0.42$66M$0.6040.70
Concentrix$9.83B0.16-$1.28B-$21.32N/A

In the previous week, Concentrix had 1 more articles in the media than Amentum. MarketBeat recorded 4 mentions for Concentrix and 3 mentions for Amentum. Concentrix's average media sentiment score of 0.89 beat Amentum's score of 0.82 indicating that Concentrix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amentum
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Concentrix
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Amentum beats Concentrix on 11 of the 17 factors compared between the two stocks.

How does Concentrix compare to Frontdoor?

Concentrix (NASDAQ:CNXC) and Frontdoor (NASDAQ:FTDR) are related companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

Concentrix has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market. Comparatively, Frontdoor has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market.

Frontdoor has lower revenue, but higher earnings than Concentrix. Concentrix is trading at a lower price-to-earnings ratio than Frontdoor, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concentrix$9.83B0.16-$1.28B-$21.32N/A
Frontdoor$2.09B2.82$255M$3.7722.26

Frontdoor has a net margin of 12.72% compared to Concentrix's net margin of -13.16%. Frontdoor's return on equity of 120.90% beat Concentrix's return on equity.

Company Net Margins Return on Equity Return on Assets
Concentrix-13.16% 19.82% 5.62%
Frontdoor 12.72%120.90%14.86%

90.3% of Concentrix shares are held by institutional investors. 0.9% of Concentrix shares are held by company insiders. Comparatively, 1.6% of Frontdoor shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Concentrix presently has a consensus price target of $32.75, indicating a potential upside of 28.43%. Frontdoor has a consensus price target of $92.00, indicating a potential upside of 9.64%. Given Concentrix's higher possible upside, equities analysts plainly believe Concentrix is more favorable than Frontdoor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Concentrix
2 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.17
Frontdoor
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Frontdoor had 20 more articles in the media than Concentrix. MarketBeat recorded 24 mentions for Frontdoor and 4 mentions for Concentrix. Concentrix's average media sentiment score of 0.89 beat Frontdoor's score of 0.76 indicating that Concentrix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concentrix
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Frontdoor
6 Very Positive mention(s)
2 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Frontdoor beats Concentrix on 12 of the 16 factors compared between the two stocks.

Get Concentrix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CNXC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNXC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CNXC vs. The Competition

MetricConcentrixProfessional Services IndustryIndustrials SectorNASDAQ Exchange
Market Cap$1.56B$7.92B$10.84B$12.94B
Dividend Yield5.60%3.77%97.10%10.20%
P/E Ratio-1.2039.0528.3624.76
Price / Sales0.1625.84348.00108.50
Price / Cash1.2022.8824.7037.44
Price / Book0.587.004.906.42
Net Income-$1.28B$238.96M$607.14M$347.27M
7 Day Performance2.20%2.19%2.14%2.52%
1 Month Performance14.86%7.80%1.63%-1.00%
1 Year Performance-45.85%-3.29%14.49%23.29%

Concentrix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNXC
Concentrix
4.8349 of 5 stars
$25.50
-0.9%
$32.75
+28.4%
-45.4%$1.56B$9.83BN/A455,000
QBTS
D-Wave Quantum
N/A$16.18
-8.3%
$36.47
+125.4%
N/A$5.99B$12.44MN/A3
LYFT
Lyft
4.3084 of 5 stars
$15.44
-0.1%
$19.40
+25.6%
+30.1%$5.86B$6.32B2.253,913
HNGE
Hinge Health
4.2442 of 5 stars
$74.26
-1.3%
$86.07
+15.9%
+56.5%$5.75B$587.86MN/A1,437
AMTM
Amentum
4.5734 of 5 stars
$21.84
-6.9%
$32.00
+46.5%
-1.5%$5.34B$14.39B36.4050,000

Related Companies and Tools


This page (NASDAQ:CNXC) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners